CU6 — Clarity Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- AU$734.66m
- AU$623.46m
- 36
- 18
- 15
- 11
Annual cashflow statement for Clarity Pharmaceuticals, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | C2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 2.01 | 2.56 | 3.34 | 8.31 | 12 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -6.83 | -7.68 | -13.3 | -27.5 | -43.2 |
| Capital Expenditures | -0.015 | -0.06 | -0.213 | -0.047 | -0.504 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | -9.5 | -26.5 | 3.2 | -54.8 |
| Change in Net Investments | |||||
| Cash from Investing Activities | -0.015 | -9.56 | -26.7 | 3.15 | -55.3 |
| Financing Cash Flow Items | 3.52 | -0.681 | -5.6 | -0.013 | -6.65 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 8.22 | 20.4 | 86.9 | 0.232 | 115 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.37 | 3.17 | 46.9 | -24.1 | 16.7 |